The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19.
Adult
Asymptomatic Diseases
COVID-19
COVID-19 Testing
Chi-Square Distribution
Clinical Laboratory Techniques
/ methods
Cohort Studies
Coronavirus Infections
/ diagnosis
Female
Gestational Age
Hospitalization
/ statistics & numerical data
Humans
Infection Control
/ methods
Infectious Disease Transmission, Vertical
/ prevention & control
New York City
Pandemics
/ prevention & control
Patient Safety
Pneumonia, Viral
/ epidemiology
Pregnancy
Pregnancy Complications, Infectious
/ prevention & control
Pregnancy Outcome
Retrospective Studies
Risk Assessment
Statistics, Nonparametric
Journal
American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
20
5
2020
medline:
8
8
2020
entrez:
20
5
2020
Statut:
ppublish
Résumé
This study was aimed to compare maternal and pregnancy outcomes of symptomatic and asymptomatic pregnant women with novel coronavirus disease 2019 (COVID-19). This is a retrospective cohort study of pregnant women with COVID-19. Pregnant women were divided into two groups based on status at admission, symptomatic or asymptomatic. All testing was done by nasopharyngeal swab using polymerase chain reaction (PCR) for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Initially, nasopharyngeal testing was performed only on women with a positive screen (symptoms or exposure) but subsequently, testing was universally performed on all women admitted to labor and delivery. Chi-square and Wilcoxon's rank-sum tests were used to compare outcomes between groups. Eighty-one patients were tested because of a positive screen (symptoms [ Pregnant women who presented with COVID19-related symptoms and subsequently tested positive for COVID-19 have a higher rate of preterm delivery and need for respiratory support than asymptomatic pregnant women. It is important to be particularly rigorous in caring for COVID-19 infected pregnant women who present with symptoms. · Respiratory support is often needed for women who present with symptoms.. · Low rate of severe disease in women who present without symptoms.. · There were no neonatal infections on day 0 of life..
Identifiants
pubmed: 32428964
doi: 10.1055/s-0040-1712164
pmc: PMC7416203
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
991-994Informations de copyright
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Déclaration de conflit d'intérêts
None declared.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Am J Obstet Gynecol. 2020 Jul;223(1):111.e1-111.e14
pubmed: 32335053
Am J Obstet Gynecol MFM. 2020 May;2(2):100118
pubmed: 32292903
Obstet Gynecol. 2019 Jan;133(1):1
pubmed: 30575675
N Engl J Med. 2020 Jun 18;382(25):e100
pubmed: 32302077
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Am J Obstet Gynecol. 2020 May;222(5):415-426
pubmed: 32105680
Transl Pediatr. 2020 Feb;9(1):51-60
pubmed: 32154135
N Engl J Med. 2020 May 28;382(22):2163-2164
pubmed: 32283004
Clin Infect Dis. 2020 Nov 19;71(16):2035-2041
pubmed: 32249918
JAMA. 2020 Apr 14;323(14):1339-1340
pubmed: 32108857
Am J Perinatol. 2020 Jun;37(8):861-865
pubmed: 32305046
JAMA. 2020 May 12;323(18):1848-1849
pubmed: 32215589
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Am J Obstet Gynecol MFM. 2020 May;2(2):100111
pubmed: 32518902